Analysis of DNA sequences from the exons of protein-coding genes constitutes a novel and cost-effective way to diagnose genetic diseases of all kinds. Many recent papers reveal how exome sequencing could contribute to novel prognostic categorization, finding new drug targets, or even clinical management changes.
